Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9JG23 | — |
expired vaccine used; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 21-year-old female patient who received HBV (Engerix B) (batch number 9JG23, expiry date 10-FEB-2025) for prophylaxis. On 01-MAR-2025, the patient received the 1st dose of Engerix B. On 01-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: expired vaccine used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-MAR-2025 Reporter had question regarding a vaccine, the hepatitis B vaccine, Engerix-B, they had a patient that received an expired vaccine, it had expired on February Tenth and the vaccine was given on March First. The patient received expired vaccine, which led to expired vaccine used.